NCT04628858

Brief Summary

Vascular postsurgical patients have a high risk of morbidity and mortality. On top of that, patients undergoing vascular surgery usually have a high burden of comorbidities. After a short stay in the post-operative ward, patients are usually transferred to a standard surgical ward. Monitoring of physiological parameters by intermittent manual recordings 8-12 hours apart, is today's standard of care in hospitals. However, no effect on length of hospital stay, morbidity or mortality has been proven. This may be due to the up to 12 hours of unobserved time that can occur, where physiological deviations can progress resulting in clinical adverse outcomes such as myocardial infarction or stroke. Vital sign micro events are occurrences when patient physiological parameters deviates significantly from what can be understood as normal physiology. Since adverse outcomes in patients rarely happens without deviating physiological parameters, it is to be investigated if micro events can be used to predict clinical adverse outcomes to patients. We acknowledge that during the observation period, the number of false alarms should be kept to a minimum to avoid the risk of 'alarm fatigue'

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 17, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 16, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 23, 2021

Completed
Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

5 months

First QC Date

November 9, 2020

Last Update Submit

April 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Physiologic abnormal vital signs - Cumulative duration

    Cumulative duration of physiologic vital signs within certain thresholds outside normalcy

    From inclusion until 4 days or discharge

Secondary Outcomes (1)

  • Physiologic abnormal vital signs - Episodes of sustained duration

    From inclusion until 4 days or discharge

Other Outcomes (4)

  • Any serious adverse events

    30 days

  • Readmission

    6 months

  • ICU admission

    6 months

  • +1 more other outcomes

Study Arms (1)

Primary group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

40 patients admitted for elective or subacute vascular surgical intervention, as noted in the inclusion criteria, will be included on the day before their surgical procedure.

You may qualify if:

  • Patients admitted to Copenhagen University Hospital
  • Patients with Peripheral Arteriel Disease(PAD)
  • Patients undergoing open infraligamentary revascularization
  • Emergency or subacute surgery
  • Admission the day before surgery, and expected length of stay more than 2 days.

You may not qualify if:

  • Patient expected not to cooperate
  • Patients with dementia or not able to give informed consent
  • Patient allergic to plaster, plastic or silicone
  • Patients with pacemaker or implantable cardioverter-defibrillator (ICD) unit
  • Patients in isolation
  • Active therapy withdrawn
  • Patients previously included in the other study branches
  • Patients with \>20 mmHg in difference in systolic blood pressure between the two arms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, 2100, Denmark

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Troponin-T

Study Officials

  • Eske K Aasvang

    Rigshospitalet, Denmark

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr. Med.

Study Record Dates

First Submitted

November 9, 2020

First Posted

November 16, 2020

Study Start

August 17, 2020

Primary Completion

January 23, 2021

Study Completion

July 23, 2021

Last Updated

April 27, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations